Latest Organofluorides Stories

2014-06-27 23:01:53

The Firm is representing a number of men and boys in Risperdal lawsuits that claim use of the atypical antipsychotic medication caused gynecomastia (male breast growth). New York, New York (PRWEB) June 27, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) continue to move forward in U.S. courts, Bernstein Liebhard LLP notes that a newly released study has linked Risperdal to low bone mass in children. The study, which was presented earlier this month at the American...

2014-06-26 23:02:56

The Firm represents Risperdal lawsuit clients in claims that allege the antipsychotic medication caused men and boys to develop gynecomastia. Rockville Centre, NY (PRWEB) June 26, 2014 The Rottenstein Law Group LLP, a national law firm that specializes in personal injury cases filed by plaintiffs with claims of harm stemming from dangerous drugs and defective medical devices, announces the launch of a new website dedicated exclusively to helping men who have been injured by the atypical...

2014-06-25 23:02:50

The Firm is representing a number of Risperdal lawsuit clients who allegedly developed gynecomastia (male breast growth) due to their use of the medication. New York, NY (PRWEB) June 25, 2014 Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) that allege the antipsychotic drug caused men and boys to develop gynecomastia, or male breast growth, continue to mount in courts around the U.S., Bernstein Liebhard LLP reports. On June 12, 2014, a 24-year-old California man filed suit...

2014-06-24 16:24:29

G-202 Data in HCC Patients (Phase I and Phase II) Highly Suggestive of Positive Clinical Activity SAN ANTONIO, June 24, 2014 /PRNewswire/ -- GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, releases the 2014 BIO International corporate presentation. Chairman and CEO, Craig Dionne, PhD, presented the company overview and clinical trial updates for G-202 at the 2014 BIO International Convention, today, Tuesday, June 24th, at...

2014-06-23 23:10:52

In Addition, The $105 Million Paxil Lawsuit Settlement with GlaxoSmithKline and Dozens of States, Prevents the Company From Paying Incentives to Drug Reps That Encourage Off-Label Use of Paxil and Other Medications. Columbus, OH (PRWEB) June 23, 2014 The Paxil birth defect lawyers at Wright & Schulte LLC note that GlaxoSmithKline has agreed to pay $105 million to resolve criminal and civil charges that it purportedly improperly marketed Paxil and other drugs. According to a report...

2014-06-23 23:05:46

Process for Filing Multidistrict Litigation Cases to be Streamlined as a Result ST. LOUIS, MO (PRWEB) June 23, 2014 The national law firm of Baron and Budd reports that the federal judge presiding over lawsuits involving the cholesterol drug Lipitor issued a Case Management Order on June 2, 2014. As a result, the process of filing new cases in the multidistrict litigation (MDL) will be streamlined. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502) In issuing the order, U.S. District...

2014-06-23 23:01:53

The Firm is representing a number of Risperdal lawsuit clients in claims that allege use of the antipsychotic medication caused men and boys to develop gynecomastia (male breast growth). New York, New York (PRWEB) June 23, 2014 Plaintiffs in Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) pending in a mass tort litigation in Pennsylvania’s Philadelphia Court of Common Pleas have responded to a defense motion seeking to have some Risperdal gynecomastia claims dismissed on...

2014-06-20 23:09:40

The San Diego personal injury lawyers of The Law Office of Melinda J. Helbock, A.P.C. are investigating potential lawsuits on behalf of boys and men who developed gynecomastia after using Risperdal. San Diego, California (PRWEB) June 20, 2014 According to a recent study, use of atypical antipsychotics in children is increasing in Australia and other countries. According to the study, more than 12,600 children under the age 19 are using antipsychotics, and the most commonly prescribed drug...

Tablet with a medicine
2014-06-19 10:33:25

Brett Smith for redOrbit.com - Your Universe Online In an attempt to raise awareness about a potential increased risk of suicide tied to antidepressant use, health officials may have made inadvertently made the problem worse. According to a new study in the British Medical Journal, FDA warnings about the increased risk of suicide and subsequent media coverage in 2003 were followed by a sudden drop in the number of prescriptions for antidepressants without compensation through increases...

2014-06-17 08:30:31

Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will present results about sexual functioning from a head-to-head study of Brintellix(®) (vortioxetine) vs. escitalopram in patients with well treated major depressive disorder (MDD) experiencing treatment-emergent sexual...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'